Search research articles
Contact Us
Filters
Showing results (71-80 of 87) with videos related to
Page
of 9
Sort By:
Biomolecules
|
September 28, 2024
Vascular Cytokines and Atherosclerosis: Differential Serum Levels of TRAIL, IL-18, and OPG in Obstructive Coronary Artery Disease
Katharine A Bate, Elijah Genetzakis, Joshua Vescovi, et al.
European Journal of Preventive Cardiology
|
July 14, 2017
Increasing proportion of ST elevation myocardial infarction patients with coronary atherosclerosis poorly explained by standard modifiable risk factors
Stephen T Vernon, Sean Coffey, Ravinay Bhindi, et al.
Nature Communications
|
August 18, 2021
A hierarchical approach to removal of unwanted variation for large-scale metabolomics data
Taiyun Kim, Owen Tang, Stephen T Vernon, et al.
BMJ Open
|
September 21, 2019
Biobanking for discovery of novel cardiovascular biomarkers using imaging-quantified disease burden: protocol for the longitudinal, prospective, BioHEART-CT cohort study
Katharine A Kott, Stephen T Vernon, Thomas Hansen, et al.
International Journal of Cardiology
|
September 30, 2022
Higher mortality in acute coronary syndrome patients without standard modifiable risk factors: Results from a global meta-analysis of 1,285,722 patients
Gwyneth Kong, Yip Han Chin, Bryan Chong, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
January 20, 2022
Immunoglobulin E Sensitization to Mammalian Oligosaccharide Galactose-α-1,3 (α-Gal) Is Associated With Noncalcified Plaque, Obstructive Coronary Artery Disease, and ST-Segment-Elevated Myocardial Infarction
Stephen T Vernon, Katharine A Kott, Thomas Hansen, et al.
Heart (British Cardiac Society)
|
June 5, 2026
Changes in the metabolome after treatment with canagliflozin in patients with type 2 diabetes
Craig Peter Coorey, Owen Tang, Mengbo Li, et al.
American Heart Journal
|
June 26, 2023
Incorporating a polygenic risk score-triaged coronary calcium score into cardiovascular disease examinations to identify subclinical coronary artery disease (ESCALATE): Protocol for a prospective, nonrandomized implementation trial
Michael P Gray, Yemima Berman, Giordano Bottà, et al.
Clinical & Translational Immunology
|
November 6, 2023
Mass cytometry analysis reveals altered immune profiles in patients with coronary artery disease
Katharine A Kott, Adam S Chan, Stephen T Vernon, et al.
American Journal of Preventive Cardiology
|
June 3, 2024
Health economic analysis of polygenic risk score use in primary prevention of coronary artery disease - A system dynamics model
Stephen T Vernon, Stuart Brentnall, Danielle J Currie, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 87) with videos related to
Sort By:
Page
of 9
Biomolecules
|
September 28, 2024
Vascular Cytokines and Atherosclerosis: Differential Serum Levels of TRAIL, IL-18, and OPG in Obstructive Coronary Artery Disease
Katharine A Bate, Elijah Genetzakis, Joshua Vescovi, et al.
European Journal of Preventive Cardiology
|
July 14, 2017
Increasing proportion of ST elevation myocardial infarction patients with coronary atherosclerosis poorly explained by standard modifiable risk factors
Stephen T Vernon, Sean Coffey, Ravinay Bhindi, et al.
Nature Communications
|
August 18, 2021
A hierarchical approach to removal of unwanted variation for large-scale metabolomics data
Taiyun Kim, Owen Tang, Stephen T Vernon, et al.
BMJ Open
|
September 21, 2019
Biobanking for discovery of novel cardiovascular biomarkers using imaging-quantified disease burden: protocol for the longitudinal, prospective, BioHEART-CT cohort study
Katharine A Kott, Stephen T Vernon, Thomas Hansen, et al.
International Journal of Cardiology
|
September 30, 2022
Higher mortality in acute coronary syndrome patients without standard modifiable risk factors: Results from a global meta-analysis of 1,285,722 patients
Gwyneth Kong, Yip Han Chin, Bryan Chong, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
January 20, 2022
Immunoglobulin E Sensitization to Mammalian Oligosaccharide Galactose-α-1,3 (α-Gal) Is Associated With Noncalcified Plaque, Obstructive Coronary Artery Disease, and ST-Segment-Elevated Myocardial Infarction
Stephen T Vernon, Katharine A Kott, Thomas Hansen, et al.
Heart (British Cardiac Society)
|
June 5, 2026
Changes in the metabolome after treatment with canagliflozin in patients with type 2 diabetes
Craig Peter Coorey, Owen Tang, Mengbo Li, et al.
American Heart Journal
|
June 26, 2023
Incorporating a polygenic risk score-triaged coronary calcium score into cardiovascular disease examinations to identify subclinical coronary artery disease (ESCALATE): Protocol for a prospective, nonrandomized implementation trial
Michael P Gray, Yemima Berman, Giordano Bottà, et al.
Clinical & Translational Immunology
|
November 6, 2023
Mass cytometry analysis reveals altered immune profiles in patients with coronary artery disease
Katharine A Kott, Adam S Chan, Stephen T Vernon, et al.
American Journal of Preventive Cardiology
|
June 3, 2024
Health economic analysis of polygenic risk score use in primary prevention of coronary artery disease - A system dynamics model
Stephen T Vernon, Stuart Brentnall, Danielle J Currie, et al.
Page
of 9